ebv-positive dlbcl, nos Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Huiqiang Huang (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadanticoagulants

I am/have/hadneutrophil count

I am/have/hadtubal ligation

I am/have/hadhigh-grade lymphoma

I am/have/hadb-cell lymphoma

I am/have/hadebv-positive dlbcl, nos

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadprothrombin time (pt)

I am/have/hadserum bilirubin

I am/have/hadpositron emission tomography

I am/have/hadcreatinine clearance rate

I am/have/hadanticoagulant therapy

I am/have/haddifficulty breathing at rest

I am/have/hadimmunodeficiency

I am/have/hadblood transfusion

I am/have/hadplatelet count

I am/have/hadmeasurable disease

I am/have/hadthyroid dysfunction

I am/have/hadfollicular lymphoma

I am/have/hadlymphoma

added new label for I am/have/had

more

I am looking for

I am looking foranticoagulants

I am looking forcolony stimulating factor

I am looking forcamrelizumab

I am looking forg-csf

I am looking forrituximab

I am looking forgranulocyte colony stimulating factor

I am looking forapatinib

I am looking for18f-fdg

I am looking fororal contraceptives

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.

neutrophil count

anticoagulants

tubal ligation

colony stimulating factor

granulocyte colony stimulating factor

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.